March 6th 2023
Lessons learned during 30 years in the industry.
February 14th 2023
February 7th 2023
FDA clears the first early-detection sepsis test in emergency department-focused diagnostic toolsJanuary 18th 2023
IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying emergency department patients with sepsis and contribute to rapid life-saving decisions.
New technologies in the clinic: Combining light-based therapies for the treatment of dry eyeDecember 19th 2022
When combined, intense pulsed light and low-level light therapy—both of which have roots in dermatology—create a synergistic effect that treat dry eye more effectively than one therapy alone.
Novartis acquires Kedalion Therapeutics and its ocular delivery platformJuly 7th 2022
The company intends to develop the AcuStream technology for potential use with its current and future front-of-eye therapies, which may include lifitegrast ophthalmic solution for the treatment of dry eye disease.
Visually-guided hearing aid: Hearing in plain sightMay 10th 2022
A prototype of a visually-guided hearing aid (VGHA) designed at Boston University of a the formed beam is manipulated by eye gaze to improve the ability of users of the technology to better focus on one sound despite the presence of nearby competing sounds.
Heru unveils two new testing modalities at Vision Expo EastMarch 31st 2022
Heru Chief Marketing Officer Brandon Barber speaks on the company's upcoming advancements and two new testing modalities on its diagnostic platform: Fast Pattern Suprathreshold Visual Field and the Farnsworth D-15 extended color vision exam.